Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Elena, Naso"'
Autor:
Nicolò Danesin, Greta Scapinello, Dorella Del Prete, Elena Naso, Tamara Berno, Andrea Visentin, Laura Bonaldi, Annalisa Martines, Roberta Bertorelle, Fabrizio Vianello, Carmela Gurrieri, Renato Zambello, Chiara Castellani, Marny Fedrigo, Stefania Rizzo, Annalisa Angelini, Livio Trentin, Francesco Piazza
Publikováno v:
Cancer Reports, Vol 7, Iss 4, Pp n/a-n/a (2024)
Abstract Background Renal injury related to Waldenström macroglobulinemia (WM) occurs in approximately 3% of patients. Kidney biopsy is crucial to discriminate between distinct histopathological entities such as glomerular (amyloidotic and non‐amy
Externí odkaz:
https://doaj.org/article/9af98db38b974f8aaa015cea7c106637
Autor:
Lorenzo A. Calò, Verdiana Ravarotto, Francesca Simioni, Elena Naso, Francesco Marchini, Luciana Bonfante, Lucrezia Furian, Paolo Rigotti
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 4, Pp 676-685 (2017)
Post-transplant hypertension is a common occurrence during treatment with calcineurin inhibitors (CNIs) in kidney transplant population. The pathogenesis of vasoconstriction induced by CNIs involves vascular tone alterations and kidney sodium transpo
Externí odkaz:
https://doaj.org/article/bd47209e6d2041a3be2641f82587737a
Autor:
Elena, Naso, Gianluca, Cuva, Roberto, Depascale, Angelini, Annalisa, Castellani, Chiara, Marny, Fedrigo, Calo', Lorenzo, DEL PRETE, Dorella
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3657::f4516c8a9ef0fdb4d6bae13473af64b7
https://hdl.handle.net/11577/3474374
https://hdl.handle.net/11577/3474374
Autor:
Samanta Beggio, Diego Maschio, Elena Naso, Monica Ceol, Lorenzo A. Calò, Marny Fedrigo, Dorella Del Prete, Franca Anglani, Lisa Gianesello, Annalisa Angelini
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in older white adults, with an incidence of 12 cases per millions of people per year. Primary MN (PMN, 75%-80% of MNs) is an organ-specific autoimmune dise
Autor:
Luca Dal Santo, Lorenzo A. Calò, Annalisa Angelini, Ugo Vertolli, Dorella Del Prete, Elena Naso, Marny Fedrigo, Laura Gobbi
Publikováno v:
Nephrology (Carlton, Vic.)
Autor:
Francesca Simioni, Luciana Bonfante, Verdiana Ravarotto, Elena Naso, Lorenzo A. Calò, Paolo Rigotti, Lucrezia Furian, Francesco Marchini
Publikováno v:
Kidney & Blood Pressure Research, Vol 42, Iss 4, Pp 676-685 (2017)
Post-transplant hypertension is a common occurrence during treatment with calcineurin inhibitors (CNIs) in kidney transplant population. The pathogenesis of vasoconstriction induced by CNIs involves vascular tone alterations and kidney sodium transpo
Autor:
Elena Naso, Elisa Pagnin, Giuseppe Maiolino, Verdiana Ravarotto, P. A. Davis, Lorenzo A. Calò
Publikováno v:
Università degli Studi di Padova-IRIS
Gitelman’s syndrome (GS) presents normo-hypotension and absence of cardiovascular–renal remodeling despite high angiotensin II (Ang II), activation of renin–angiotensin–aldosterone system and is a human model of endogenous antagonism of Ang I
Autor:
Agostino Naso, Paul A. Davis, Verdiana Ravarotto, Lorenzo A. Calò, Elena Naso, Elisa Pagnin, Giuseppe Maiolino, Mario Lupia, Ugo Vertolli
Publikováno v:
Life Sciences. 148:80-85
Cardiovascular disease (CVD) is the leading cause of excess mortality in chronic kidney disease (CKD) and dialysis patients (DP) who have higher prevalence of left ventricular hypertrophy (LVH), the strongest predictor of CV events. Rho kinase (ROCK)
Autor:
Elisa Pagnin, Elena Naso, Agostino Naso, Giuseppe Maiolino, Paul A. Davis, Gianni Carraro, Verdiana Ravarotto, Lorenzo A. Calò
Publikováno v:
Università degli Studi di Padova-IRIS
Hypothesis/Introduction: Angiotensin II (Ang II) has been shown to control erythropoietin (EPO) synthesis as Ang II type 1 receptor (AT1R) blockers block Ang-II-induced EPO oversecretion. To further explore the involvement of AT1R in processes contro
Publikováno v:
Artificial Organs. 39:736-740
Multiple observational studies along with a limited number of randomized clinical trials suggest that intensive hemodialysis (IHD) not only improves outcomes for uremic patients undergoing chronic dialysis but does so with a more favorable cost/benef